Glaukos submitted an NDA for Epioxa, a novel corneal cross-linking therapy for keratoconus, to the US FDA. Epioxa's Phase 3 ...

Investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines among about 9,000 patients in a practice.

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for. This series features experts in ophthalmology sharing their ...

Faricimab shows superior durability and efficacy in treating neovascular AMD, DME, and CRVO, allowing for extended treatment intervals and reduced burden. In DME cases, faricimab outperformed ...

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

4D-150, based on the R100 vector, shows superior retinal cell transduction and efficacy in preclinical models compared to AAV2. The genetic medicine 4D-150 targets neovascular retinopathies by ...

According to Iridex Corp., the study confirms MicroPulse TLT's sustained safety and efficacy in managing glaucoma, reducing ...